Therapeutic Angiogenesis With Basic Fibroblast Growth Factor: Technique and Early Results Frank W Sellke, MD, Roger J Laham, MD, Elazer R Edelman, MD, PhD, Justin D Pearlman, MD, PhD, Michael Simons, MD The Annals of Thoracic Surgery Volume 65, Issue 6, Pages 1540-1544 (June 1998) DOI: 10.1016/S0003-4975(98)00340-3
Fig 1 Placement of heparin-alginate beads containing basic fibroblast growth factor (bFGF) in the nongraftable ischemic right coronary artery myocardial territory and border zone between the ischemic right coronary artery and grafted left anterior descending coronary artery territories. The Annals of Thoracic Surgery 1998 65, 1540-1544DOI: (10.1016/S0003-4975(98)00340-3)
Fig 2 Resting thallium (REST TL) and exercise sestamibi (EX MIBI) technetium scans demonstrating improved perfusion at rest and during exercise in the nongrafted inferior wall (arrows) myocardium 3 months after (B) placement of heparin-alginate beads containing basic fibroblast growth factor compared with that before (A) placement of beads. (ANT = anterior; AP = apex; HLA = horizontal long axis; INF = inferior; SA = short axis; SEP = septal; VLA = vertical long axis.) The Annals of Thoracic Surgery 1998 65, 1540-1544DOI: (10.1016/S0003-4975(98)00340-3)